Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV and the kidney.

Frank A Post1, Bruce M Hendry

  • 1Academic Department of HIV/Genitourinary Medicine, King's College London, London SE5 9RJ.

British Journal of Hospital Medicine (London, England : 2005)
|April 22, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>APOL1</i> Variants, AKI, and Progression to Kidney Failure in People of African Ancestry Living with HIV.

Kidney international reports·2026
Same author

Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials.

Open forum infectious diseases·2026
Same author

Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir-based antiretroviral therapy.

HIV medicine·2026
Same author

Safety and biologic activity of a bispecific T cell receptor targeting HIV Gag in males living with HIV: a first-in-human trial.

Nature communications·2026
Same author

Screening for Trypanosoma cruzi infection (Chagas disease) in the Latin American population living with HIV in London.

HIV medicine·2026
Same author

Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/ml and history of K103N mutation.

AIDS (London, England)·2026
Same journal

Beyond the High: A Narrative Review of the Chronic Complications of Recreational Ketamine Use.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Prolonged Undiagnosed Prodromal Symptoms.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Human Factors and Deterioration: What Success Factors Facilitate Escalation of Care and How Can These Be Applied More Reliably?

British journal of hospital medicine (London, England : 2005)·2026
Same journal

Comparative Evaluation of Functional Outcomes and Postoperative Complications After Minimally Invasive Fixation for Acromioclavicular Joint Injuries.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

A Systematic Review of Functional MRI Studies on Seasonal Modulation of Brain Functional Connectivity.

British journal of hospital medicine (London, England : 2005)·2026
Same journal

More Than Myocarditis? Cardiac Involvement in Phaeochromocytoma-A Case Report.

British journal of hospital medicine (London, England : 2005)·2026
See all related articles

Kidney disease is a serious complication of HIV. Effective antiretroviral therapy improves life expectancy for HIV patients with kidney failure, making them candidates for kidney replacement therapies like transplantation.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Immunology

Background:

  • Kidney disease is a significant health issue for individuals with Human Immunodeficiency Virus (HIV) infection.
  • Advances in antiretroviral therapy (ART) have substantially increased the lifespan of HIV-positive individuals.
  • End-stage renal disease (ESRD) presents a critical challenge for HIV-infected populations.

Purpose of the Study:

  • To highlight the impact of HIV on kidney health.
  • To emphasize the benefits of antiretroviral therapy in managing HIV-associated kidney disease.
  • To advocate for the inclusion of HIV-positive patients in renal replacement therapy programs.

Main Methods:

  • Review of current medical literature on HIV and kidney disease.
  • Analysis of outcomes data for HIV-infected patients undergoing renal replacement therapy.

Related Experiment Videos

  • Evaluation of the efficacy and safety of antiretroviral therapy in ESRD patients.

    • Main Results:

    • Antiretroviral therapy has significantly improved survival rates for HIV-infected patients with end-stage renal disease.
    • HIV-positive patients with ESRD demonstrate improved quality of life and longevity with appropriate medical management.
    • Successful outcomes are achievable with renal replacement therapies, including kidney transplantation.

    Conclusions:

    • HIV-infected patients with end-stage renal disease benefit significantly from antiretroviral therapy.
    • Renal replacement therapy, such as kidney transplantation, is a viable and recommended option for HIV-positive individuals with ESRD.
    • Comprehensive care integrating infectious disease and nephrology management is crucial for this patient population.